Technology transfer is at the core of our being. By nature, we are committed to disseminating and transferring discoveries to academic centers and industrial partners with a view to ensuring the optimal exploitation of research results for the benefit of the society at large.

ImmuneHealth, a collective research centre from the Walloon Region which designs and performs clinical investigations according to strict standards required by pharmaceutical companies and regulatory authorities, is our privileged partner for translational projects.

Currently, we benefit from a portfolio of 7 Patents families including 2 granted patents and 25 patents applications

• METHOD TO DETERMINE IN VIVO NUCLEIC ACID LEVELS

Inventors : Patrick Stordeur, Michel Goldman
Priority date : 18.01.2002
Reference : PCT/EP03/00493

• GAMMA DELTA T CELL ACTIVATORS AS VACCINE ADJUVANTS

Inventors : Jamila Ismaili, Michel Goldman
Patent sold to Innate-Pharma S.A., Marseille, France

• DEVICE, KIT AND METHOD FOR PULSING BIOLOGICAL SAMPLE WITH AN AGENT AND STABILISING THE SAMPLE SO PULSED

Inventors : Patrick Stordeur, Ling Zhou, Michel Goldman
Priority date : 10.07.2003
Reference : PCT/EP03/07453
Basis of research agreement with DNAVISION S.A.  

• GENERATION AND USE OF A NEW TYPE OF DENDRITIC CELLS FOR IMMUNOTHERAPY

Inventors : Christel Buelens, Fabienne Willems, Michel Goldman
Priority date : 24.05.2004
Reference : 00870273.0 EP/0 199461.5 ; PCT/EPO1/13189
Patent licensed to BruCells S.A.

• METHOD FOR EVALUATING THE RESPONSE OF AN INDIVIDUAL TO A TREATMENT WITH A TYPE I INTERFERON (IFN)

Inventors : Patrick Stordeur, Mathieu Vokaer, Annick Ocmant, Michel Goldman
Priority date  : 25.01.2007
Reference : PCT/EP2007/07447004.8

• PROPHYLACTIC AND THERAPEUTIC USE OF SELECTED AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS IN AUTOIMMUNE DISEASES
  
  Inventors : Dominique De Wit, Stanislas Goriely, Michel Goldman
  Priority date : 19.04.2007
  Reference : EP 07106520.5
  
  

• NEW MARKER FOR DIAGNOSIS OF ACTIVE MULTIPLE SCLEROSIS
  
  Inventors : P. Stordeur, F. Villée, M. Vokaer, A. Ocmant and M. Goldman.
  Priority date : 27.03.09
  Application N° : EP No. 09156388.2

• TRANSGENIC ORGANISS EXPRESSING CD40L AS VACCINE TOOLS

  Inventors : Mustapha Chamekh, Abdelmounaïm Allaoui, Michel Goldman, Bernard Vray
  Priority date : 07.04.2005
  Reference : PCT/EP2006/003159

• USE OF PURINERGIC AND PYRIMIDINERGIC RECEPTOR AGONISTS AS IMMUNOMODULATORS

  Inventors : Jean-Marie Boeynaems, Michel Goldman, Frederic Marteau, Didier Communi
  Priority date : 12.08.2005
  Reference : PCT/EP2006/007066

• INHIBITORS OF CONVENTIONAL PROTEIN KINASE C ISOZYMES AND USE THEREOF FOR TREATING INFLAMATORY DISEASES

  Inventors : Cécile Springael, Séverine Thomas, Michel Goldman, Ezra Aksoy, Fabienne Willems
  Priority date : 19.09.2006
  Reference : PCT/EP2006/009085

• DIAGNOSTIC METHOD AND KIT FOR THE DETECTION OF LYMPHOCYTIC VARIANT HYPEREOSINOPHILIC SYNDROME

  Inventors: Karen Willard-Gallo, Catherine Sibille, Florence Roufosse
  Priority date: 08.07.2009
  Reference: BP. ULBB.155A/EP

• NEW BIOMARKERS FOR DETERMINING ALLERGY STATUS
  
  
  Inventors: Haïfa Hamdi, Patrick Stordeur, Annick Ocmant
  Priority date: 02.11.2009
  Reference: PCT/EP2009/064455